6-169633047-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_182552.5(WDR27):c.2123G>A(p.Arg708Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000536 in 1,586,654 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_182552.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WDR27 | NM_182552.5 | c.2123G>A | p.Arg708Gln | missense_variant | 21/26 | ENST00000448612.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WDR27 | ENST00000448612.6 | c.2123G>A | p.Arg708Gln | missense_variant | 21/26 | 1 | NM_182552.5 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152218Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000767 AC: 19AN: 247600Hom.: 0 AF XY: 0.0000521 AC XY: 7AN XY: 134330
GnomAD4 exome AF: 0.0000342 AC: 49AN: 1434318Hom.: 0 Cov.: 30 AF XY: 0.0000382 AC XY: 27AN XY: 707714
GnomAD4 genome AF: 0.000236 AC: 36AN: 152336Hom.: 0 Cov.: 33 AF XY: 0.000282 AC XY: 21AN XY: 74508
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 14, 2024 | The c.2123G>A (p.R708Q) alteration is located in exon 21 (coding exon 20) of the WDR27 gene. This alteration results from a G to A substitution at nucleotide position 2123, causing the arginine (R) at amino acid position 708 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at